4.83
6.39%
+0.29
Eagle Pharmaceuticals Inc 주식(EGRX)의 최신 뉴스
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K
GlobeNewswire Inc.
Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio
GlobeNewswire Inc.
Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City
GlobeNewswire Inc.
Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q
GlobeNewswire Inc.
Eagle Pharmaceuticals Announces Management Change
GlobeNewswire Inc.
Down -33.75% in 4 Weeks, Here's Why Eagle Pharmaceuticals (EGRX) Looks Ripe for a Turnaround
Zacks Investment Research
Top 4 Health Care Stocks That Could Blast Off This Quarter
Benzinga
자본화:
|
볼륨(24시간):